Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
for Acute Myeloid Leukemia
22 locations incl. New Haven
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 18+
Code: NCT06484062·Phase 1·Recruiting